✦ LIBER ✦

Phase II study of high central dose Gamma Knife radiosurgery and marimastat in patients with recurrent malignant glioma

✍ Scribed by David A Larson; Michael Prados; Kathleen R Lamborn; Vernon Smith; Penny K Sneed; Susan Chang; Kelly M Nicholas; William M Wara; Daniel Devriendt; Sandeep Kunwar; Mitch Berger; Michael W McDermott

Book ID: 108435037
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 159 KB
Volume: 54
Category: Article
ISSN: 0360-3016
DOI: 10.1016/s0360-3016(02)03743-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of carboplatin and chro

A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant glioma

✍ P. Tang; G. Roldan; P.M.A Brasher; D. Fulton; W. Roa; A. Murtha; J.G. Cairncross 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 195 KB

Phase I Dose Escalation Trial of Vandeta

Phase I Dose Escalation Trial of Vandetanib With Fractionated Radiosurgery in Patients With Recurrent Malignant Gliomas

✍ Emma C. Fields; Denise Damek; Laurie E. Gaspar; Arthur K. Liu; Brian D. Kavanagh 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 387 KB

Phase II study of homoharringtonine in p

Phase II study of homoharringtonine in patients with recurrent primary malignant central nervous system tumors

✍ Lynn G. Feun; Niramol Savaraj; Howard Landy; Howard Levin; Theodore Lampidis 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 337 KB

A Randomized Phase II and Pharmacokineti

A Randomized Phase II and Pharmacokinetic Study of Dacarbazine in Patients with Recurrent Glioma

✍ S. Vincent Rajkumar; Joel M. Reid; Paul J. Novotny; Stephanie L. Safgren; Bernd 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 38 KB

A Phase II Study of KRN8602(MX2), a Nove

A Phase II Study of KRN8602(MX2), a Novel Morpholino Anthracycline Derivative, in Patients with Recurrent Malignant Glioma

✍ Jun-Ichi Kuratsu; Norio Arita; Kaoru Kurisu; Toru Uozumi; Toru Hayakawa; Yukitak 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 31 KB

Phase II study of high-dose tamoxifen (N

Phase II study of high-dose tamoxifen (NSC-180973) in patients with disseminated malignant melanoma

✍ Edward T. Creagan; James N. Ingle; David L. Ahmann; Stephanie J. Green 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 3 views

Seventeen patients with disseminated malignant melanoma received a daily oral regimen of tamoxifen, 100 mg/m2. All patients had prior chemotherapy and predominantly visceral involvement. None of the patients had an objective regression and most (71%) had progressive disease at the time of first reas